NCT03023527 - Nivolumab Role in the Treatment of Patients With Refractory or Relapse Multiple Myeloma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Multiple Myeloma

Interventions

DRUG

Nivolumab

DRUG

Pomalidomide

DRUG

Dexamethasone

DRUG

Elotuzumab

Trial Locations (12)

ICO Badalona, Badalona

Hospital Clinic, Barcelona

Hospital Universitario Virgen de las Nieves, Granada

Hospital Universitario de Canarias, Las Palmas de Gran Canaria

Hospital Ramón y Cajal, Madrid

Hospital Universitario 12 de octubre, Madrid

Hospital Morales Messeguer, Murcia

Hospital Central de Asturias, Oviedo

Hospital Son Llatzer, Palma de Mallorca

Clinica Universidad de Navarra, Pamplona

Hospital Universitario de Salamanca, Salamanca

Complejo Hospitalario Regional Virgen del Rocío, Seville